{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:20:19Z","timestamp":1787685619246,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41375-026-03021-1","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:43:05Z","timestamp":1783064585000},"page":"1935-1950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1\/DUSP2 axis to prevent CAR T cell exhaustion"],"prefix":"10.1038","volume":"40","author":[{"given":"Jia-Yue","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Si","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Jie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Zhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Qin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"3021_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","volume":"129","author":"M Sanchez-Martin","year":"2017","unstructured":"Sanchez-Martin M, Ferrando A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. 2017;129:1124\u201333.","journal-title":"Blood"},{"key":"3021_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood.2022017755","volume":"141","author":"M Simonin","year":"2023","unstructured":"Simonin M, Andrieu GP, Birsen R, Balsat M, Hypolite G, Courtois L, et al. Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL. Blood. 2023;141:1353\u20138.","journal-title":"Blood"},{"key":"3021_CR3","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1182\/blood.2023022920","volume":"145","author":"P P\u00f6l\u00f6nen","year":"2025","unstructured":"P\u00f6l\u00f6nen P, Mullighan CG, Teachey DT. Classification and risk stratification in T-lineage acute lymphoblastic leukemia. Blood. 2025;145:1464\u201374.","journal-title":"Blood"},{"key":"3021_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400024","volume":"11","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Li H, Lu Q, Zhang Z, Li J, Wang Z, et al. mRNA-engineered CD5-CAR-\u03b3\u03b4TCD5- cells for the immunotherapy of T-cell acute lymphoblastic leukemia. Adv Sci. 2024;11:2400024.","journal-title":"Adv Sci"},{"key":"3021_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1182\/blood-2015-02-629527","volume":"126","author":"M Mamonkin","year":"2015","unstructured":"Mamonkin M, Rouce RH, Tashiro H, Brenner MK. A T-cell\u2013directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood. 2015;126:983\u201392.","journal-title":"Blood"},{"key":"3021_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1182\/blood-2017-01-761320","volume":"130","author":"D Gomes-Silva","year":"2017","unstructured":"Gomes-Silva D, Srinivasan M, Sharma S, Lee CM, Wagner DL, Davis TH, et al. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017;130:285\u201396.","journal-title":"Blood"},{"key":"3021_CR7","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","volume":"127","author":"JH Park","year":"2016","unstructured":"Park JH, Geyer MB, Brentjens RJ. CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood. 2016;127:3312\u201320.","journal-title":"Blood"},{"key":"3021_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103508","volume":"9","author":"M Shao","year":"2022","unstructured":"Shao M, Teng X, Guo X, Zhang H, Huang Y, Cui J, et al. Inhibition of calcium signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via SOCE-calcineurin-NFAT and glycolysis pathways. Adv Sci. 2022;9:e2103508.","journal-title":"Adv Sci"},{"key":"3021_CR9","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1016\/j.ymthe.2021.07.001","volume":"29","author":"Z Dai","year":"2021","unstructured":"Dai Z, Mu W, Zhao Y, Jia X, Liu J, Wei Q, et al. The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains. Mol Ther. 2021;29:2707\u201322.","journal-title":"Mol Ther"},{"key":"3021_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00822-w","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li C, Du M, Jiang H, Luo W, Tang L, et al. Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies. Blood Cancer J. 2023;13:61.","journal-title":"Blood Cancer J"},{"key":"3021_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101390","volume":"47","author":"Z Rashidijahanabad","year":"2020","unstructured":"Rashidijahanabad Z, Huang X. Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy. Semin Immunol. 2020;47:101390.","journal-title":"Semin Immunol"},{"key":"3021_CR12","first-page":"801","volume":"41","author":"X Jing","year":"2019","unstructured":"Jing X, Liang H, Hao C, Yang X, Cui X. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Oncol Rep. 2019;41:801\u201310.","journal-title":"Oncol Rep"},{"key":"3021_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2577","volume":"12","author":"A Cazet","year":"2010","unstructured":"Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P. Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res. 2010;12:204.","journal-title":"Breast Cancer Res"},{"key":"3021_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102174","volume":"69","author":"D Ince","year":"2022","unstructured":"Ince D, Lucas TM, Malaker SA. Current strategies for characterization of mucin-domain glycoproteins. Curr Opin Chem Biol. 2022;69:102174.","journal-title":"Curr Opin Chem Biol"},{"key":"3021_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.molmed.2019.10.003","volume":"26","author":"M Bose","year":"2020","unstructured":"Bose M, Mukherjee P. Microbe\u2013MUC1 crosstalk in cancer-associated infections. Trends Mol Med. 2020;26:324\u201336.","journal-title":"Trends Mol Med"},{"key":"3021_CR16","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1074\/jbc.M109.065169","volume":"285","author":"RP Aryal","year":"2010","unstructured":"Aryal RP, Ju T, Cummings RD. The endoplasmic reticulum chaperone cosmc directly promotes in vitro folding of T-synthase*. J Biol Chem. 2010;285:2456\u201362.","journal-title":"J Biol Chem"},{"key":"3021_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1083\/jcb.200711151","volume":"182","author":"T Ju","year":"2008","unstructured":"Ju T, Aryal RP, Stowell CJ, Cummings RD. Regulation of protein O-glycosylation by the endoplasmic reticulum\u2013localized molecular chaperone cosmc. J Cell Biol. 2008;182:531\u201342.","journal-title":"J Cell Biol"},{"key":"3021_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.immuni.2016.05.014","volume":"44","author":"AD Posey","year":"2016","unstructured":"Posey AD, Schwab RD, Boesteanu AC, Steentoft C, Mandel U, Engels B, et al. Engineered CAR T cells targeting the cancer-associated tn-glycoform of the membrane mucin MUC1 control adenocarcinoma. Immunity. 2016;44:1444\u201354.","journal-title":"Immunity"},{"key":"3021_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ijc.23493","volume":"123","author":"Y Cao","year":"2008","unstructured":"Cao Y, Merling A, Karsten U, Goletz S, Punzel M, Kraft R, et al. Expression of CD175 (tn), CD175s (sialosyl-tn) and CD176 (thomsen-friedenreich antigen) on malignant human hematopoietic cells. Int J Cancer. 2008;123:89\u201399.","journal-title":"Int J Cancer"},{"key":"3021_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2141.2006.06331.x","volume":"135","author":"S Cloosen","year":"2006","unstructured":"Cloosen S, Gratama J, Van Leeuwen EBM, Senden-Gijsbers BLMG, Oving EBH, Von Mensdorff-Pouilly S, et al. Cancer specific mucin-1 glycoforms are expressed on multiple myeloma. Br J Haematol. 2006;135:513\u20136.","journal-title":"Br J Haematol"},{"key":"3021_CR21","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1039\/C6CS00858E","volume":"46","author":"N Mart\u00ednez-S\u00e1ez","year":"2017","unstructured":"Mart\u00ednez-S\u00e1ez N, Peregrina JM, Corzana F. Principles of mucin structure: Implications for the rational design of cancer vaccines derived from MUC1-glycopeptides. Chem Soc Rev R Soc Chem. 2017;46:7154\u201375.","journal-title":"Chem Soc Rev R Soc Chem"},{"key":"3021_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101389","volume":"47","author":"DM Beckwith","year":"2020","unstructured":"Beckwith DM, Cudic M. Tumor-associated O-glycans of MUC1: carriers of the glyco-code and targets for cancer vaccine design. Semin Immunol. 2020;47:101389.","journal-title":"Semin Immunol"},{"key":"3021_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41591-019-0564-6","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner RG, Mackall CL. Clinical lessons learned from the first leg of the CAR T cell journey. Nat Med. 2019;25:1341\u201355.","journal-title":"Nat Med"},{"key":"3021_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01986-y","volume":"9","author":"X Wang","year":"2024","unstructured":"Wang X, Tao X, Chen P, Jiang P, Li W, Chang H, et al. MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-fos and JunB. Sig Transduct Target Ther. 2024;9:1\u201319.","journal-title":"Sig Transduct Target Ther"},{"key":"3021_CR25","doi-asserted-by":"crossref","unstructured":"Cherkassky L, Morello A, Villena-Vargas J, Feng Y, Dimitrov DS, Jones DR, et al. Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition. J Clin Invest. 2016;126:3130\u201344.","DOI":"10.1172\/JCI83092"},{"key":"3021_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ijc.33212","volume":"148","author":"F Fan","year":"2021","unstructured":"Fan F, Yoo HJ, Stock S, Wang L, Liu Y, Schubert M-L, et al. Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients. Int J Cancer. 2021;148:419\u201328.","journal-title":"Int J Cancer"},{"key":"3021_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","volume":"629","author":"JD Chan","year":"2024","unstructured":"Chan JD, Scheffler CM, Munoz I, Sek K, Lee JN, Huang Y-K, et al. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature. 2024;629:201\u201310.","journal-title":"Nature"},{"key":"3021_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/blood.2021011597","volume":"139","author":"CR Funk","year":"2022","unstructured":"Funk CR, Wang S, Chen KZ, Waller A, Sharma A, Edgar CL, et al. PI3K\u03b4\/\u03b3 inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood. 2022;139:523\u201337.","journal-title":"Blood"},{"key":"3021_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41375-017-0008-6","volume":"32","author":"W Zheng","year":"2018","unstructured":"Zheng W, O\u2019Hear CE, Alli R, Basham JH, Abdelsamed H, Palmer LE, et al. PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells. Leukemia. 2018;32:1157\u201367.","journal-title":"Leukemia"},{"key":"3021_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep31740","volume":"6","author":"JJ Lohmueller","year":"2016","unstructured":"Lohmueller JJ, Sato S, Popova L, Chu IM, Tucker MA, Barberena R, et al. Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential. Sci Rep. 2016;6:31740.","journal-title":"Sci Rep"},{"key":"3021_CR31","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3389\/fimmu.2018.01605","volume":"9","author":"A Angajala","year":"2018","unstructured":"Angajala A, Lim S, Phillips JB, Kim J-H, Yates C, You Z, et al. Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism. Front Immunol. 2018;9:1605.","journal-title":"Front Immunol"},{"key":"3021_CR32","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41590-020-0786-2","volume":"21","author":"MA Ataide","year":"2020","unstructured":"Ataide MA, Komander K, Kn\u00f6pper K, Peters AE, Wu H, Eickhoff S, et al. BATF3 programs CD8+ T cell memory. Nat Immunol. 2020;21:1397\u2013407.","journal-title":"Nat Immunol"},{"key":"3021_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41590-019-0577-9","volume":"21","author":"Dan Lu","year":"2020","unstructured":"Dan Lu, Liu L, Sun Y, Song J, Yin Q, Zhang G, et al. The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity. Nat Immunol. 2020;21:287\u201397.","journal-title":"Nat Immunol"},{"key":"3021_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23044-9","volume":"12","author":"MV Wagle","year":"2021","unstructured":"Wagle MV, Vervoort SJ, Kelly MJ, Van Der Byl W, Peters TJ, Martin BP, et al. Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance. Nat Commun. 2021;12:2782.","journal-title":"Nat Commun"},{"key":"3021_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107906","volume":"98","author":"F Sun","year":"2021","unstructured":"Sun F, Yue T-T, Yang C-L, Wang F-X, Luo J-H, Rong S-J, et al. The MAPK dual specific phosphatase (DUSP) proteins: a versatile wrestler in T cell functionality. Int Immunopharmacol. 2021;98:107906.","journal-title":"Int Immunopharmacol"},{"key":"3021_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cellsig.2015.01.010","volume":"27","author":"K Hamamura","year":"2015","unstructured":"Hamamura K, Nishimura A, Chen A, Takigawa S, Sudo A, Yokota H. Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis. Cell Signal. 2015;27:828\u201335.","journal-title":"Cell Signal"},{"key":"3021_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155380","volume":"140","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang P, Yu Y, Huang E, Yao Y, Guo D, et al. Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R\/EGR1\/PDGF-BB signaling pathway. Metabolism. 2023;140:155380.","journal-title":"Metabolism"},{"key":"3021_CR38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.bbrc.2016.08.059","volume":"478","author":"Y Ma","year":"2016","unstructured":"Ma Y, Han C-C, Li Y, Wang Y, Wei W. Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine\/paracrine loops. Biochem Biophys Res Commun. 2016;478:964\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3021_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-024-06989-9","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Liu C, Yang L, Tan X, Chen S, et al. Neoplastic ICAM-1 protects lung carcinoma from apoptosis through ligation of fibrinogen. Cell Death Dis. 2024;15:1\u201315.","journal-title":"Cell Death Dis"},{"key":"3021_CR40","first-page":"7462","volume":"63","author":"S Wintterle","year":"2003","unstructured":"Wintterle S, Schreiner B, Mitsdoerffer M, Schneider D, Chen L, Meyermann R, et al. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res. 2003;63:7462\u20137.","journal-title":"Cancer Res"},{"key":"3021_CR41","doi-asserted-by":"publisher","first-page":"e003760","DOI":"10.1136\/jitc-2021-003760","volume":"10","author":"F Guo","year":"2022","unstructured":"Guo F, Das JK, Kobayashi KS, Qin Q-M, A Ficht T, Alaniz RC, et al. Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment. J Immunother Cancer. 2022;10:e003760.","journal-title":"J Immunother Cancer"},{"key":"3021_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00262-023-03618-w","volume":"73","author":"X Zhang","year":"2024","unstructured":"Zhang X, Sun R, Zhang M, Zhao Y, Cao X, Guo R, et al. A CAR-T response prediction model for r\/r B-NHL patients based on a T cell subset nomogram. Cancer Immunol Immunother. 2024;73:33.","journal-title":"Cancer Immunol Immunother"},{"key":"3021_CR43","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, Jaccard A, Romero P, Yu Y-R, Ho P-C. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab Nat Publ Group. 2020;2:1001\u201312.","journal-title":"Nat Metab Nat Publ Group"},{"key":"3021_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03165-x","volume":"19","author":"M Zhang","year":"2021","unstructured":"Zhang M, Jin X, Sun R, Xiong X, Wang J, Xie D, et al. Optimization of metabolism to improve efficacy during CAR-T cell manufacturing. J Transl Med. 2021;19:499.","journal-title":"J Transl Med"},{"key":"3021_CR45","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med. 2015;21:581\u201390.","journal-title":"Nat Med"},{"key":"3021_CR46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","volume":"44","author":"OU Kawalekar","year":"2016","unstructured":"Kawalekar OU, O\u2019Connor RS, Fraietta JA, Guo L, McGettigan SE, Posey AD, et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity. 2016;44:380\u201390.","journal-title":"Immunity"},{"key":"3021_CR47","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1038\/s41588-023-01554-0","volume":"55","author":"SR McCutcheon","year":"2023","unstructured":"McCutcheon SR, Swartz AM, Brown MC, Barrera A, McRoberts Amador C, Siklenka K, et al. Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens. Nat Genet. 2023;55:2211\u201323.","journal-title":"Nat Genet"},{"key":"3021_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coviro.2020.10.003","volume":"46","author":"K Kanev","year":"2021","unstructured":"Kanev K, Zehn D. Origin and fine-tuning of effector CD8 T cell subpopulations in chronic infection. Curr Opin Virol. 2021;46:27\u201335.","journal-title":"Curr Opin Virol"},{"key":"3021_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.990419","volume":"14","author":"H Niu","year":"2023","unstructured":"Niu H, Wang H. TOX regulates T lymphocytes differentiation and its function in tumor. Front Immunol. 2023;14:990419.","journal-title":"Front Immunol"},{"key":"3021_CR50","doi-asserted-by":"crossref","unstructured":"Collins SM, Alexander KA, Lundh S, Dimitri AJ, Zhang Z, Good CR, et al. TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells. Sci Adv. 2023;9:eadh2605.","DOI":"10.1126\/sciadv.adh2605"},{"key":"3021_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102199","volume":"6","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Chen S, Zhao J, Du X, Yin H, Zhou C, et al. EGFR TKIs suppress MUC1 glycosylation through the PI3K\/AKT\/SP1\/C1GALT1 pathway to enhance TnMUC1 CAR-T efficacy in EGFR-mutant NSCLC. Cell Rep Med. 2025;6:102199.","journal-title":"Cell Rep Med"},{"key":"3021_CR52","first-page":"4799","volume":"85","author":"J Li","year":"2025","unstructured":"Li J, Sun Y, Xia Y, Lou J, Guo J, Rong L, et al. Abstract 4799: MSLN and MUC1 dual-targeting CAR-T with conditional activation and tumor specificity to improve clinical safety and efficacy. Cancer Res Am Assoc Cancer Res. 2025;85:4799\u20134799.","journal-title":"Cancer Res Am Assoc Cancer Res"},{"key":"3021_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj6251","volume":"10","author":"L Lu","year":"2024","unstructured":"Lu L, Xie M, Yang B, Zhao W-B, Cao J. Enhancing the safety of CAR-T cell therapy: synthetic genetic switch for spatiotemporal control. Sci Adv. 2024;10:eadj6251.","journal-title":"Sci Adv"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03021-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:02:40Z","timestamp":1787684560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03021-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3021"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03021-1","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was approved by the Ethics Committee of Zhujiang Hospital of Southern Medical University and is in accordance with the guidelines of the Declaration of Helsinki (2025-KY-244). INFORMED consent was obtained from all individual participants (or their legal guardians) for their participation in the study, including the collection and use of tissue samples for research purposes. Animal experiments were approved by the Animal Ethics Committee of Zhujiang Hospital of Southern Medical University (2024-098).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}